FDA receives applications for generic Mounjaro, Zepbound

Generic versions of Mounjaro and Zepbound could be in the works after the FDA agreed to review two applications from Swiss ...
Medscape

Some Patients With Sleep Apnea Benefit the Most From Tirzepatide

The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.
Healthline

Generic Mounjaro, Zepbound May Be Coming, Rivaling Current GLP-1s

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...
AOL

Why Zepbound Became the First Drug FDA-Cleared Specifically for Obstructive Sleep Apnea

The buzz around Ozempic just got louder. A new wave of research suggests GLP-1 drugs may quietly be reshaping how doctors think about sleep apnea, one of the most underdiagnosed conditions in America.
AOL

Shaquille O’Neal Shares How Zepbound Helped with Sleep Apnea and Weight Loss

NEW YORK, NEW YORK – MAY 12: Shaquille O'Neal attends the 2026 Disney Upfront at Jacob K. Javits Convention Center on May 12, 2026 in New York City. (Photo by John Nacion/FilmMagic) Shaquille O'Neal ...

Saxenda vs. Zepbound For Weight Loss: What’s The Difference?

If you want to talk to your health care provider about weight loss medications, Saxenda and Zepbound are two options you may ...
Morningstar

With Zepbound approved for sleep apnea, Lilly spends up to $7.8 billion for a company with a narcolepsy drug

Eli Lilly is spending up to $7.8 billion to buy Centessa, which is working on treatments for sleep-wake disorders. Eli Lilly has made yet another deal, this time buying a drug company that's ...

Contrave vs. Zepbound For Weight Loss: What’s The Difference?

Contrave and Zepbound are two U.S. Food and Drug Administration (FDA)-approved medications for weight loss when combined with diet and exercise. But each medication works in different ways in the body ...